Home » Medical Devices » Drug Eluting Stents Market

Drug Eluting Stents Market By Product (Polymer Based Coating, Polymer Free Coating), By Application (Peripheral Artery Disease, Coronary Artery Disease) – Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Name: Drug Eluting Stents Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2017-12-01
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Drug Eluting Stents Market

Summary
Table Of Content
Request Sample

According to the World Health Organization’s 2015 statistics, 82% of the 17 million premature deaths occurred in low and middle-income countries, with cardiovascular diseases accounting for 37% of these. The risk factors identified are associated with the worsening of the disease etiology related to cardiac complications ae, binge drinking, smoking, obesity, ty and type 2 diabetes is important to understand that blood vessel diseases have no symptoms; a heart attack or stroke are considered warning signs for the underlying diseases. Drug-eluting stents are important in cardiovascular complications because they are a minimally invasive surgical procedure that broadens constricted blood vessels and helps patients live longer lives.t.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Polymer-based coating and polymer-free coating have been included in the product segment. Polymer-based coatings are further sub-segmented as non-biodegradable and biodegradable polymer-based coatings. Polymer-free coatings comprise microporous surfaces, microstructured surfaces, slotted tubular surfaces, and nanoporous surfaces. The application segment comprises peripheral artery disease and coronary artery disease. With respect to the scope of the report, market estimation and forecasts for the period 2015–2025 are included in the document.

The scope of the report includes market sizing and data forecasts for the country’s cross-sectional.

Porter’s five forces model has been included in the scope of the report and gives a holistic view of the market dynamics prevalent in the drug-eluting stent market. The competitive landscape is a very useful study that gives insights regarding the competition faced by the major companies trying to gain a strong foothold in the drug-eluting stent market. The major players in the global drug-eluting stents market are Stentys, Abbott Laboratories, Inc., Biosensors International Group, Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology, Medtronics Plc, Terumo Medical Corporation, and Shandong JW Medical Systems.

Based on product, the global drug-eluting stents market is categorized into

Polymer-Based Coating

- non-biodegradable polymer-based
- Biodegradable polymer-based
Polymer-Free Coating
- Microporous Surface
- Microstructured Surface
- Slotted Tubular Surface
- Nanoporous Surface

Atherosclerotic plaques, which consist of cholesterol, fat, calcium, and other inflammatory substances present in the blood, usually build up in the arteries. It is of prime importance to understand the fatal outcomes of untreated atherosclerotic plaques, which may lead to stroke, heart attack, and death in severe cases. Polymer-free coated stents dominate the market due to their faster drug elution rate. Microporous surface stents are gaining tremendous demand due to their reduction of in-stent restenosis. Nanoporous surfaces have excellent features, such as higher drug loading capacity, which drives the market for polymer-free coating stents. Polymer-based coatings are gaining good momentum as they are useful in addressing the problems of local inflammation and neointimal hyperplasia by suppressing them and also providing sustained and controlled drug release for a longer period of time. The major players in the drug-eluting stents market are Abbott Laboratories, Inc., Biosensors International Group, Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology, Medtronics Plc, Terumo Medical Corporation, Shandong JW Medical Systems, Stentys.

Based on application, the global drug-eluting stents market is categorized into

Peripheral Artery Disease
Coronary Artery Disease

According to the World Health Organization, cardiovascular diseases are one of the prime causes of global deaths, accounting for 17.7 million deaths each year, which represents 31 percent of the deaths worldwide. Increased consumption of fast food, a profound smoking habit, obesity, and stress account for the morbidity due to stroke and heart attacks. It is noteworthy that 80% of all cardiovascular deaths are due to either strokes or heart attacks, which occur due to the narrowing of arteries due to atherosclerotic plaques causing hypertension and a reduced supply of oxygen. Coronary artery disease is the most prevalent condition in cardiovascular complications due to the increasing number of patients suffering from type-2 diabetes, excessive alcohol consumption, high levels of C-reactive proteins, and consumption of a poor diet deficient in vitamins E, D, and C. Peripheral artery disease is spreading at a faster pace as the blockage of arteries in the proximities causes claudication while walking and climbing erectile dysfunction in men, and sores and wounds of the feet that heal poorly.

For the purpose of this study, the global market for drug-eluting stents is categorized into the following regional and country-specific markets:

North America

- U.S.
- Canada
Europe
- U.K.
- Germany
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- rest of Latin America
Middle East and Africa
- GCC
- Rest of the Middle East and Africa

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

North American dominance is related to the rising prevalence of the cardiovascular disease. The American Heart Association, in its 2017 Heart Disease and Strokes Statistics, has reported that cardiovascular disease is responsible for the deaths of around 800,000 U.S. citizens, which is equivalent to one in every three deaths. Sedentary lifestyles and rising consumption of saturated food products contribute to the growth of the North American drug-eluting stent market. The European market is driven by the rising prevalence of type 2 diabetes and obesity. The presence of pharmaceutical companies manufacturing drug-eluting stents represents Europe’s market growth for drug-eluting stents. The presence of a large baby boomer population with cardiovascular complications, increasing public health awareness, and a supportive regulatory environment for drug-eluting stents drive the Asia Pacific market. Increased government spending on the establishment of developed healthcare centers, as well as foreign direct investment by healthcare medical device manufacturers, will drive the drug-eluting stent market in the Middle East, Africa, and Latin America to new heights.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Drug Eluting Stents Market Portraiture
2.1.1. Global Drug Eluting Stents Market, by Product, 2016 (Value %)
2.1.2. Global Drug Eluting Stents Market, by Application, 2016 (Value %)
2.1.3. Global Drug Eluting Stents Market, by Geography, 2016 (Value %)

Chapter 3. Drug Eluting Stents Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Attractive Investment Proposition, by Geography
3.7. Top 3 Countries: Global Drug Eluting Stents Market, 2015-2025 (US$ Mn)
3.8. Competitive Landscape : Global Drug Eluting Stents Market, by Key Players 2015-2025 (US$ Mn)

Chapter 4. Global Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Drug Eluting Stents Market, by Product, 2016
4.3. Polymer Based Coating
4.3.1. Non-Biodegradable Polymer Based
4.3.2. Biodegradable Polymer Based
4.4. Polymer Free Coating
4.4.1. Micro Porous Surface
4.4.2. Microstructured Surface
4.4.3. Slotted Tubular Surface
4.4.4. Nanoporous Surface

Chapter 5. Global Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Drug Eluting Stents Market, by Application, 2016
5.2. Peripheral Artery Disease
5.3. Coronary Artery Disease

Chapter 6. Global Drug Eluting Stents Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Drug Eluting Stents Market Analysis, 2015 – 2025
6.2.1. North America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Drug Eluting Stents Market Analysis, 2015 – 2025
6.3.1. Europe Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Drug Eluting Stents Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of Asia Pacific
6.5. Latin America Drug Eluting Stents Market Analysis, 2015 – 2025
6.5.1. Latin America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Drug Eluting Stents Market Analysis, 2015 – 2025
6.6.1. Middle East and Africa Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. Middle East and Africa Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. Middle East and Africa Drug Eluting Stents Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of Middle East and Africa

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Biosensors International Group
7.3. Biotronik
7.4. Boston Scientific Corporation
7.5. Cook Medical
7.6. Lepu Medical Technology
7.7. Medtronics Plc
7.8. Terumo Medical Corporation
7.9. Shandong JW Medical Systems
7.10. Stentys

List of Figures

FIG. 1 Drug Eluting Stents: Market Segmentation
FIG. 2 Global Drug Eluting Stents Market Share, by Product, 2016 (Value %)
FIG. 3 Global Drug Eluting Stents Market, by Application, 2016 (Value %)
FIG. 4 Global Drug Eluting Stents Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Non-Biodegradable Polymer Based Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Biodegradable Polymer Based Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Micro Porous Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Microstructured Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Slotted Tubular Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Nanoporous Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Peripheral Artery Disease Market for Drug Eluting Stents, 2015 – 2025 (US$ Mn)
FIG. 14 Global Coronary Artery Disease Market for Drug Eluting Stents, 2015 – 2025 (US$ Mn)
FIG. 15 U.S. Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 16 Canada Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 17 U.K. Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 18 Germany Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 19 Rest of Europe Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 20 Japan Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 21 China Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 22 India Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest of Asia Pacific Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 24 Brazil Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 25 Mexico Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 26 Rest of Latin America Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 27 GCC Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Middle East and Africa Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Drug Eluting Stents Market Portraiture
TABLE 2 Global Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 3 Global Polymer Based Coating Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 4 Global Polymer Free Coating Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 5 Global Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 Global Drug Eluting Stents Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 7 North America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 8 North America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 North America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Drug Eluting Stents Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 22 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Biosensors International Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Biotronik: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Cook Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Lepu Medical Technology: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Medtronics Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Terumo Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Shandong JW Medical Systems: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Stentys: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions

What is the size of Drug Eluting Stents Market?

The market for Drug Eluting Stents is expected to reach US$ 8,377.9 Mn in 2025.

What is the Drug Eluting Stents Market CAGR?

The Drug Eluting Stents market is expected to see significant CAGR growth over the coming years,at 5.67%.

What is the Forecast period considered for Drug Eluting Stents Market?

The report is forecasted from 2017-2025.

What is the base year considered for Drug Eluting Stents Market?

The base year of this report is 2016.

Who are the major players in this Market?

Abbott Laboratories Inc.,Biosensors International Group,Biotronik,Boston Scientific Corporation,Cook Medical are some of the major players in the global market.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Methotrexate Drugs Market

The Methotrexate drugs market is projected to grow from USD 654.3 million in 2024 to an estimated USD 989 million by 2032, with a compound annual growth rate (CAGR) of 5.3% from 2024 to 2032.

3D Printed Drugs Market

The 3D Printed Drugs Market was valued at USD 371.4 million in 2024 and is anticipated to reach USD 784.6 million by 2032, expanding at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.

Fibrate Drugs Market

Fibrate Drugs Market size stood at USD 3,572.5 million in 2024 and is projected to reach USD 5,355.1 million by 2032, registering a CAGR of 5.19% during the forecast period.

Anti-Obesity Drugs Market

The Anti-Obesity Drugs Market size was valued at USD 3,250.0 million in 2018 to USD 6,980.4 million in 2024 and is anticipated to reach USD 36,326.2 million by 2032, at a CAGR of 23.0% during the forecast period.

India Anti-Obesity Drugs Market

The India Anti-Obesity Drugs Market size was valued at USD 30.1 million in 2018 to USD 239.0 million in 2024 and is anticipated to reach USD 3,451.1 million by 2032, at a CAGR of 39.7% during the forecast period.

Epilepsy Treatment Drugs Market

The Epilepsy Treatment Drugs Market size was valued at USD 11739.4 million in 2024 and is anticipated to reach USD 18291.4 million by 2032, at a CAGR of 5.7% during the forecast period (2024-2032).

Veterinary Dermatology Drugs Market

The Veterinary Dermatology Drugs Market size was valued at USD 17309 million in 2024 and is anticipated to reach USD 35514.8 million by 2032, at a CAGR of 9.4% during the forecast period (2024-2032).

Organoids in Drug Discovery Market

The Organoids in Drug Discovery Market size was valued at USD 677.4 million in 2018 to USD 1,709.2 million in 2024 and is anticipated to reach USD 6,152.1 million by 2032, at a CAGR of 17.54% during the forecast period.

Tumor Necrosis Factor Inhibitor Drugs Market

The Tumor Necrosis Factor Inhibitor Drugs Market is projected to grow from USD 44,950 million in 2024 to USD 67,430.3 million by 2032, expanding at a CAGR of 5.2%.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample